2017 5 5103 425 1,076 49 AbbVie was incorporated in Delaware on April 10, 2012. on January 1, 2011 Above became an independent, publicly traded company as a result of the distribution by Abbott Laboratories (Abbott) of 100of the standing common stock of Abbvieto Abbott's shareholder Year ended December 31 (in million) (brackets denote cash outlow! 2015 2018 Cash flows from operating activities Net earning 7.12 $ S6 Adjustments to recondie net earning to net cash from operating activities Depreciation 464 471 Amortisation of intangible assets 1553 1294 Change in fair value of content consideration Baits 1091 Stock based compensation 430 421 Upfront costs and milestones related to collaboration 490 1061 Gainon divestitures (330) Intangible asset impairment 1010 5.070 Impacts related to US tax reform 424 Othernet 41 Ounces in operating assets and abilities Accounts receivable 1741 1591) Inventores 1231) 1226) Prepaid expenses and other as 97 (499) Accounts payable and other abilities (1,1211 150 Cash flow from operating activities 13,324 13.427 626 365 470 354 1.242 84 76 (391) 93 (118) 425 9.960 a). Is AbbVie generating cash? (7 pts) 1 b). How can you tell AbbVie is generating cash? (7 pts) c). Why are they adding back the depreciation and amortization here? (6 pts) Focus